Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washington University with a Master of Science in Health Care Quality after earning a Bachelor of Science in Nursing from San Pedro College Davao, in the Philippines.

Kim Formica, Revenue/Billing Director

Kim Formica is Director of Revenue Cycle and Billing Compliance at Regional Cancer Care Associates. Formica has four years of experience in oncology billing and collections, is a certified professional coder (CPC), and has more 20 years of prior healthcare billing and operations experience. Prior to joining RCCA, she was Director of Billing/Collections for Medical Resources, Inc., a freestanding imaging company that operated in nine states. Her oversight included reporting from five remote regional billing centers. Her current responsibilities include assuring billing compliance and maintaining oversight of RCCA daily reconciliations.

Alizah Diamond, Corporate Counsel

Alizah Diamond is Corporate Counsel–Commercial Contracts and Employment at Regional Cancer Care Associates (RCCA). She is responsible for oversight of RCCA’s legal matters, including commercial contracts and transactions, healthcare regulatory compliance, mergers and acquisitions, employment/HR matters, and other areas that impact RCCA’s clinical office and commercial business lines.

Prior to joining RCCA, Alizah was an attorney at Schnader Harrison Segal & Lewis LLP and Hodes Ulman Pessin & Katz, P.A., representing companies in commercial and employment transactions and litigation in a wide range of industries. She received her J.D. from Georgetown University Law Center and her B.A. from the Johns Hopkins University. Alizah was named a New York City Super Lawyers “Rising Star” in 2014 and 2015. She is licensed to practice law in Maryland, New Jersey (In-House) and New York.

Frank Casamassima, Chief Technology Officer at Regional Cancer Care Associates

Frank Casamassima is Chief Technology Officer at Regional Cancer Care Associates where he is responsible for the management, security, and support of information systems and telecommunications. His primary duty is to provide strategic vision through technology that align with the business objectives of RCCA. Frank has 29 years of IT experience in various industries which include 19 years in healthcare and was most recently employed at HHCS Inc. where he managed a chain of nursing homes, adult day care facilities, health care agencies, and a retirement community. Frank graduated from New York Institute of Technology with a Bachelor of Science in Electrical Engineering.

Cheryl Hermansen, Director, Data Analysis and Business Intelligence

Cheryl Hermansen is Director of Data Analysis and Business Intelligence for Regional Cancer Care Associates responsible for the Enterprise Information Management (EIM) program.  She provides the vision and strategy for all data management activities including how data is gathered, utilized, and protected.  Her responsibilities include handling data service provider relationships across the enterprise.  Cheryl comes to RCCA with over 20 years of applied experience; 17 years in the Healthcare Pharmaceuticals industry.  She brings strong audit, compliance, data mining, data analysis, data quality, control and testing, business requirements elicitation and documentation, process improvement, project management, Master Data Management, Business Intelligence, as well as vendor and client servicing skills.  Cheryl graduated Cume Laude with a Bachelor of Business Administration, obtained her CPA in NY State, and CBAP with the IIBA.

Lisa A Ferrante, Assistant Director of Revenue Cycle for Regional Cancer Care Associates

Her responsibilities include oversight of the revenue cycle team. Lisa is a Certified Professional Coder with over 16 years of healthcare experience. She has a proven track record of success with focus on optimizing profits for hospital systems, home health and hospice agencies, ambulatory surgery centers, and large scale physician groups. Throughout Lisa’s career she combines project management and comprehensive solutions to create process roadmaps. Her management has shown proven results with increasing revenue by maximizing performance, streamlining efficiencies and enhancing the overall patient experience. She holds a BS in Business Administration from Lehigh University. Lisa has volunteered at Gilda’s Club, and Avon’s Walk for Breast Cancer, she was a spokesperson for Englewood Hospital and Medical Center’s Leslie Simon Breast Care Center.

Maria Strama, Laboratory Manager for Regional Cancer Care Associates.

Maria Strama is the Laboratory Manager for Regional Cancer Care Associates. Her primary responsibility includes planning, organizing and directing the overall operation of the clinical laboratory department.  She develops laboratory procedures to ensure safety, security, quality and accuracy of test results.  Additionally, she functions as a technical expert in maintaining proficiency testing, equipment maintenance, while maintaining all Federal, State and Laboratory Accreditation guidelines and acts as a Compliance officer for all RCCA laboratory locations.

She is passionate about providing exceptional patient care in the laboratory setting and she strives to bring the lab to the highest standard. In the short time she has been with RCCA, she has earned the “Lab of Excellence” award from COLA, our accrediting agency.  Prior to joining RCCA, she spent 25 years in a hospital clinical lab setting. She holds a BS in Allied Health from Montclair State University.

Andre Goy, MD, Chief Science Officer

As Chief Science Officer and Director of Research and Innovation, Dr. Andre Goy is responsible for developing strategies that will bring research and clinical trials to all RCCA locations. Under Dr. Goy’s leadership, patients in local communities throughout New Jersey will be able to access cutting-edge clinical trials focused on novel therapies and biomarker-driven research.

Dr. Goy also continues to serve as Chairman and Executive Director at John Theurer Cancer Center at Hackensack University Medical Center, one of the 50 best hospitals for cancer and RCCA’s Hackensack location, where he has been instrumental in elevating the research program to become one of the largest, most active in the nation. The research program now includes more than 200 clinical trials across 14 cancer divisions with Phase I, II and III protocols. Dr. Goy also spearheaded the development of the Tissue Bank, and leads New Jersey’s largest program for lymphoma.

An internationally renowned clinician and researcher, Dr. Goy is widely known for his work showing the first evidence of activity of bortezomib (Velcade) in mantle cell lymphoma, which led to the FDA’s approval of bortezomib for relapsed/refractory mantle cell lymphoma. He also took part in the original pilot study for rituximab (Rituxan), which has been widely used to treat lymphomas, leukemias, and autoimmune disorders. He is currently the global lead investigator for lenalidomide for patients with relapsed/refractory mantle cell lymphoma for whom bortezomib had failed. Dr. Goy is also the co-investigator in a number of clinical trials in lymphomas, including the very promising kinase inhibitors targeting the BCR pathway, especially ibrutinib, which showed dramatic activity in a number of B-cell lymphomas, especially mantle cell lymphoma.

Dr. Goy has trained at the world’s leading medical institutions, including Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center, Assistance Publique in Paris (the largest university hospital system in Europe), and The Pasteur Institute, also in Paris.

Michael Ruiz de Somocurcio, VP–Payer & Provider Collaboration

Michael Ruiz de Somocurcio is Vice President–Payer and Provider Collaboration for Regional Cancer Care Associates. His responsibilities include contracting, data analytics, developing value-based arrangements with health plans and CMS, and supporting growth strategies in new and existing markets. Prior to joining RCCA, he spent more than 15 years on the health plan side working for national, regional and start-up health plans. Most recently, he held COO and VP roles at Amerigroup, Oscar Insurance and AmeriHealth NJ, where he led network contracting, strategic initiatives and medical cost containment. Throughout his career, Ruiz de Somocurcio has developed innovative partnerships to transform the delivery of care through network design and value-based outcomes between health plans, hospitals and physician groups. He holds a BS in Business Administration from the College of NJ and an MBA from Rutgers University. He speaks locally and nationally on a broad range of healthcare topics but is most passionate about improving the healthcare delivery system.

Lani M. Alison, BSN. MS.-HCQ PCMH CCE, Vice President Clinical Affairs

Lani M. Alison is Vice President–Clinical Affairs at Regional Cancer Care Associates. She is responsible for implementing the Oncology Medical Home model of care across all RCCA practices. This model of care includes integration and coordination of care and services provided to RCCA’s patients from the time the referral is received, during the patient treatment, and into the patient’s journey into survivorship or supportive palliative care. She designs strategies and tactics to realize the vision and mission of RCCA’s clinical and administrative leadership. Alison also oversees programmatic implementation utilizing a cyclical process of continuous quality improvement guided by a talented pool of people and well tested processes that are supported by state-of-the-art technology. She is responsible for the overall quality, patient-safety and outcome initiatives that put RCCA at the forefront of value-based programs in oncology. Lani has extensive background in payer and provider initiatives, and prior to joining RCCA she worked for integrated healthcare systems where she designed and implemented systematic care-coordination practices and transformation of ambulatory practices into Patient Centered Medical Homes (PCMHs). Lani graduated from George Washing